Creasallis

Creasallis is a biopharmaceutical company that develops antibody therapeutics, specifically for cancer treatment. Their CreaTap technology is designed to enhance the penetration of antibody-based drugs into solid tumors.

CreaTap technology
Monoclonal antibodies
Bispecific antibodies
IP management services
Antibody drug conjugates
Protein and peptide conjugates

Size

Small

Phone

N/A

Website

creasallis.com

N/A

Locations

babraham research park, CB22 3AT

07957933599

8:30 - 18:00

Digital Popularity

Social Media

LinkedIn
1,659 Followers

Competitors

Cell Guidance Systems

Cell Guidance Systems develops innovative products and services that enhance human health and support scientific research.

Stemnovate

Stemnovate is a pioneering company focused on building animal models for drug discovery in the pharmaceutical and animal health industries.

Domainex

Domainex is a leading integrated drug discovery services provider that collaborates with life science organisations to accelerate the development of new medicines.

Company Details

Creasallis is operated by Creasallis Ltd and is a Active company incorporated on 15 June 2021 with the registered office located in Cambridge, Cambridgeshire. Creasallis Ltd was registered 4 years ago.

Status

Active

Size

Micro

Directors

Age

4 years old

Employees

Turnover

Unreported

Total Assets

£365.96K